DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Analytical platform evaluation for quantification of ERG in prostate cancer using protein and mRNA detection methods

Abstract

Background: The established methods for detecting prostate cancer (CaP) are based on tests using PSA (blood), PCA3 (urine), and AMACR (tissue) as biomarkers in patient samples. The demonstration of ERG oncoprotein overexpression due to gene fusion in CaP has thus provided ERG as an additional biomarker. Based on this, we hypothesized that ERG protein quantification methods can be of use in the diagnosis of prostate cancer. Methods: Therefore, an antibody-free assay for ERG3 protein detection was developed based on PRISM (high-pressure high-resolution separations with intelligent selection and multiplexing)-SRM (selected reaction monitoring) mass spectrometry. We utilized TMPRSS2-ERG positive VCaP and TMPRSS2-ERG negative LNCaP cells to simulate three different sample types (cells, tissue, and post-DRE urine sediment). Results: Recombinant ERG3 protein spiked into LNCaP cell lysates could be detected at levels as low as 20 pg by PRISM-SRM analysis. The sensitivity of the PRISM-SRM assay was around approximately 10,000 VCaP cells in a mixed cell population model of VCaP and LNCaP cells. Interestingly, ERG protein could be detected in as few as 600 VCaP cells spiked into female urine. The sensitivity of the in-house enzyme-linked immunosorbent assay (ELISA) was similar to the PRISM-SRM assay, with detection of 30 pg of purified recombinantmore » ERG3 protein and 10,000 VCaP cells. On the other hand, qRT-PCR exhibited a higher sensitivity, as TMPRSS2-ERG transcripts were detected in as few as 100 VCaP cells, in comparison to NanoString methodologies which detected ERG from 10,000 cells. Conclusions: Based on this data, we propose that the detection of both ERG transcriptional products with RNA-based assays, as well as protein products of ERG using PRISM-SRM assays, may be of clinical value in developing diagnostics and prognostics assays for prostate cancer given their sensitivity, specificity, and reproducibility.« less

Authors:
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; more »; ; ; ; « less
Publication Date:
Research Org.:
Pacific Northwest National Laboratory (PNNL), Richland, WA (United States). Environmental Molecular Sciences Laboratory (EMSL)
Sponsoring Org.:
USDOE
OSTI Identifier:
1184918
Report Number(s):
PNNL-SA-107827
Journal ID: ISSN 1479-5876; 48505; 400412000
Grant/Contract Number:  
AC05-76RL01830
Resource Type:
Accepted Manuscript
Journal Name:
Journal of Translational Medicine
Additional Journal Information:
Journal Volume: 13; Journal Issue: 1; Journal ID: ISSN 1479-5876
Country of Publication:
United States
Language:
English
Subject:
59 BASIC BIOLOGICAL SCIENCES; Environmental Molecular Sciences Laboratory

Citation Formats

He, Jintang, Schepmoes, Athena A., Shi, Tujin, Wu, Chaochao, Fillmore, Thomas L., Gao, Yuqian, Smith, Richard D., Qian, Weijun, Rodland, Karin D., Liu, Tao, Camp, David G., Rastogi, Anshu, Tan, Shyh-Han, Yan, Wusheng, Mohamed, Ahmed A., Huang, Wei, Banerjee, Sreedatta, Kagan, Jacob, Srivastava, Sudhir, McLeod, David, Srivastava, Shiv, Petrovics, Gyorgy, Dobi, Albert, and Srinivasan, Alagarsamy. Analytical platform evaluation for quantification of ERG in prostate cancer using protein and mRNA detection methods. United States: N. p., 2015. Web. doi:10.1186/s12967-015-0418-z.
He, Jintang, Schepmoes, Athena A., Shi, Tujin, Wu, Chaochao, Fillmore, Thomas L., Gao, Yuqian, Smith, Richard D., Qian, Weijun, Rodland, Karin D., Liu, Tao, Camp, David G., Rastogi, Anshu, Tan, Shyh-Han, Yan, Wusheng, Mohamed, Ahmed A., Huang, Wei, Banerjee, Sreedatta, Kagan, Jacob, Srivastava, Sudhir, McLeod, David, Srivastava, Shiv, Petrovics, Gyorgy, Dobi, Albert, & Srinivasan, Alagarsamy. Analytical platform evaluation for quantification of ERG in prostate cancer using protein and mRNA detection methods. United States. https://doi.org/10.1186/s12967-015-0418-z
He, Jintang, Schepmoes, Athena A., Shi, Tujin, Wu, Chaochao, Fillmore, Thomas L., Gao, Yuqian, Smith, Richard D., Qian, Weijun, Rodland, Karin D., Liu, Tao, Camp, David G., Rastogi, Anshu, Tan, Shyh-Han, Yan, Wusheng, Mohamed, Ahmed A., Huang, Wei, Banerjee, Sreedatta, Kagan, Jacob, Srivastava, Sudhir, McLeod, David, Srivastava, Shiv, Petrovics, Gyorgy, Dobi, Albert, and Srinivasan, Alagarsamy. Thu . "Analytical platform evaluation for quantification of ERG in prostate cancer using protein and mRNA detection methods". United States. https://doi.org/10.1186/s12967-015-0418-z. https://www.osti.gov/servlets/purl/1184918.
@article{osti_1184918,
title = {Analytical platform evaluation for quantification of ERG in prostate cancer using protein and mRNA detection methods},
author = {He, Jintang and Schepmoes, Athena A. and Shi, Tujin and Wu, Chaochao and Fillmore, Thomas L. and Gao, Yuqian and Smith, Richard D. and Qian, Weijun and Rodland, Karin D. and Liu, Tao and Camp, David G. and Rastogi, Anshu and Tan, Shyh-Han and Yan, Wusheng and Mohamed, Ahmed A. and Huang, Wei and Banerjee, Sreedatta and Kagan, Jacob and Srivastava, Sudhir and McLeod, David and Srivastava, Shiv and Petrovics, Gyorgy and Dobi, Albert and Srinivasan, Alagarsamy},
abstractNote = {Background: The established methods for detecting prostate cancer (CaP) are based on tests using PSA (blood), PCA3 (urine), and AMACR (tissue) as biomarkers in patient samples. The demonstration of ERG oncoprotein overexpression due to gene fusion in CaP has thus provided ERG as an additional biomarker. Based on this, we hypothesized that ERG protein quantification methods can be of use in the diagnosis of prostate cancer. Methods: Therefore, an antibody-free assay for ERG3 protein detection was developed based on PRISM (high-pressure high-resolution separations with intelligent selection and multiplexing)-SRM (selected reaction monitoring) mass spectrometry. We utilized TMPRSS2-ERG positive VCaP and TMPRSS2-ERG negative LNCaP cells to simulate three different sample types (cells, tissue, and post-DRE urine sediment). Results: Recombinant ERG3 protein spiked into LNCaP cell lysates could be detected at levels as low as 20 pg by PRISM-SRM analysis. The sensitivity of the PRISM-SRM assay was around approximately 10,000 VCaP cells in a mixed cell population model of VCaP and LNCaP cells. Interestingly, ERG protein could be detected in as few as 600 VCaP cells spiked into female urine. The sensitivity of the in-house enzyme-linked immunosorbent assay (ELISA) was similar to the PRISM-SRM assay, with detection of 30 pg of purified recombinant ERG3 protein and 10,000 VCaP cells. On the other hand, qRT-PCR exhibited a higher sensitivity, as TMPRSS2-ERG transcripts were detected in as few as 100 VCaP cells, in comparison to NanoString methodologies which detected ERG from 10,000 cells. Conclusions: Based on this data, we propose that the detection of both ERG transcriptional products with RNA-based assays, as well as protein products of ERG using PRISM-SRM assays, may be of clinical value in developing diagnostics and prognostics assays for prostate cancer given their sensitivity, specificity, and reproducibility.},
doi = {10.1186/s12967-015-0418-z},
journal = {Journal of Translational Medicine},
number = 1,
volume = 13,
place = {United States},
year = {Thu Jan 01 00:00:00 EST 2015},
month = {Thu Jan 01 00:00:00 EST 2015}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record

Citation Metrics:
Cited by: 21 works
Citation information provided by
Web of Science

Save / Share:

Works referenced in this record:

Chromosome aberrations in solid tumors
journal, July 2003

  • Albertson, Donna G.; Collins, Colin; McCormick, Frank
  • Nature Genetics, Vol. 34, Issue 4
  • DOI: 10.1038/ng1215

erg, a human ets-related gene on chromosome 21: alternative splicing, polyadenylation, and translation
journal, August 1987


The erg gene: a human gene related to the ets oncogene.
journal, September 1987

  • Reddy, E. S.; Rao, V. N.; Papas, T. S.
  • Proceedings of the National Academy of Sciences, Vol. 84, Issue 17
  • DOI: 10.1073/pnas.84.17.6131

Decrease and Gain of Gene Expression Are Equally Discriminatory Markers for Prostate Carcinoma
journal, June 2002


Recurrent gene fusions in prostate cancer
journal, June 2008

  • Kumar-Sinha, Chandan; Tomlins, Scott A.; Chinnaiyan, Arul M.
  • Nature Reviews Cancer, Vol. 8, Issue 7
  • DOI: 10.1038/nrc2402

Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome
journal, March 2005


Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
journal, October 2005


5′ UTR Control of Native ERG and of Tmprss2:ERG Variants Activity in Prostate Cancer
journal, March 2013


Diversity of TMPRSS2-ERG fusion transcripts in the human prostate
journal, October 2006


ETS2 function is required to maintain the transformed state of human prostate cancer cells
journal, December 1998

  • Sementchenko, Victor I.; Schweinfest, Clifford W.; Papas, Takis S.
  • Oncogene, Vol. 17, Issue 22
  • DOI: 10.1038/sj.onc.1202220

Beyond PSA: The Next Generation of Prostate Cancer Biomarkers
journal, March 2012


Urine TMPRSS2:ERG Fusion Transcript Stratifies Prostate Cancer Risk in Men with Elevated Serum PSA
journal, August 2011


ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification
journal, June 2010

  • Furusato, B.; Tan, S-H; Young, D.
  • Prostate Cancer and Prostatic Diseases, Vol. 13, Issue 3
  • DOI: 10.1038/pcan.2010.23

Antibody-Based Detection of ERG Rearrangement-Positive Prostate Cancer
journal, July 2010

  • Park, Kyung; Tomlins, Scott A.; Mudaliar, Kumaran M.
  • Neoplasia, Vol. 12, Issue 7
  • DOI: 10.1593/neo.10726

ERG Monoclonal Antibody in the Diagnosis and Biological Stratification of Prostate Cancer: Delineation of Minimal Epitope, Critical Residues for Binding, and Molecular Basis of Specificity
journal, August 2014

  • Rastogi, Anshu; Tan, Shyh-Han; Banerjee, Sreedatta
  • Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, Vol. 33, Issue 4
  • DOI: 10.1089/mab.2014.0026

ERG protein expression and genomic rearrangement status in primary and metastatic prostate cancer—a comparative study of two monoclonal antibodies
journal, January 2012

  • Braun, M.; Goltz, D.; Shaikhibrahim, Z.
  • Prostate Cancer and Prostatic Diseases, Vol. 15, Issue 2
  • DOI: 10.1038/pcan.2011.67

Predominance of ERG-negative high-grade prostate cancers in African American men
journal, August 2014

  • Farrell, James; Young, Denise; Chen, Yongmei
  • Molecular and Clinical Oncology, Vol. 2, Issue 6
  • DOI: 10.3892/mco.2014.378

Low Frequency of the ERG Oncogene Alterations in Prostate Cancer Patients from India
journal, January 2013

  • Rawal, Sudhir; Young, Denise; Williams, Molly
  • Journal of Cancer, Vol. 4, Issue 6
  • DOI: 10.7150/jca.6568

Advancing the sensitivity of selected reaction monitoring-based targeted quantitative proteomics
journal, April 2012


Selected reaction monitoring for quantitative proteomics: a tutorial
journal, January 2008

  • Lange, Vinzenz; Picotti, Paola; Domon, Bruno
  • Molecular Systems Biology, Vol. 4, Issue 1
  • DOI: 10.1038/msb.2008.61

Selected reaction monitoring–based proteomics: workflows, potential, pitfalls and future directions
journal, May 2012

  • Picotti, Paola; Aebersold, Ruedi
  • Nature Methods, Vol. 9, Issue 6
  • DOI: 10.1038/nmeth.2015

Antibody-free, targeted mass-spectrometric approach for quantification of proteins at low picogram per milliliter levels in human plasma/serum
journal, September 2012

  • Shi, T.; Fillmore, T. L.; Sun, X.
  • Proceedings of the National Academy of Sciences, Vol. 109, Issue 38
  • DOI: 10.1073/pnas.1204366109

Targeted Quantification of Low ng/mL Level Proteins in Human Serum without Immunoaffinity Depletion
journal, June 2013

  • Shi, Tujin; Sun, Xuefei; Gao, Yuqian
  • Journal of Proteome Research, Vol. 12, Issue 7
  • DOI: 10.1021/pr400178v

Antibody-independent targeted quantification of TMPRSS2-ERG fusion protein products in prostate cancer
journal, February 2014


Skyline: an open source document editor for creating and analyzing targeted proteomics experiments
journal, February 2010


Direct multiplexed measurement of gene expression with color-coded probe pairs
journal, February 2008

  • Geiss, Gary K.; Bumgarner, Roger E.; Birditt, Brian
  • Nature Biotechnology, Vol. 26, Issue 3
  • DOI: 10.1038/nbt1385

mRNA transcript quantification in archival samples using multiplexed, color-coded probes
journal, January 2011

  • Reis, Patricia P.; Waldron, Levi; Goswami, Rashmi S.
  • BMC Biotechnology, Vol. 11, Issue 1
  • DOI: 10.1186/1472-6750-11-46

The Present and Future of Prostate Cancer Urine Biomarkers
journal, June 2013

  • Rigau, Marina; Olivan, Mireia; Garcia, Marta
  • International Journal of Molecular Sciences, Vol. 14, Issue 6
  • DOI: 10.3390/ijms140612620

Prospective Multicentre Evaluation of PCA3 and TMPRSS2-ERG Gene Fusions as Diagnostic and Prognostic Urinary Biomarkers for Prostate Cancer
journal, March 2014


Advancing the sensitivity of selected reaction monitoring-based targeted quantitative proteomics
journal, April 2012


Prospective Multicentre Evaluation of PCA3 and TMPRSS2-ERG Gene Fusions as Diagnostic and Prognostic Urinary Biomarkers for Prostate Cancer
journal, March 2014


Targeted Quantification of Low ng/mL Level Proteins in Human Serum without Immunoaffinity Depletion
journal, June 2013

  • Shi, Tujin; Sun, Xuefei; Gao, Yuqian
  • Journal of Proteome Research, Vol. 12, Issue 7
  • DOI: 10.1021/pr400178v

Selected reaction monitoring for quantitative proteomics: a tutorial
journal, January 2008

  • Lange, Vinzenz; Picotti, Paola; Domon, Bruno
  • Molecular Systems Biology, Vol. 4, Issue 1
  • DOI: 10.1038/msb.2008.61

Direct multiplexed measurement of gene expression with color-coded probe pairs
journal, February 2008

  • Geiss, Gary K.; Bumgarner, Roger E.; Birditt, Brian
  • Nature Biotechnology, Vol. 26, Issue 3
  • DOI: 10.1038/nbt1385

Chromosome aberrations in solid tumors
journal, July 2003

  • Albertson, Donna G.; Collins, Colin; McCormick, Frank
  • Nature Genetics, Vol. 34, Issue 4
  • DOI: 10.1038/ng1215

Selected reaction monitoring–based proteomics: workflows, potential, pitfalls and future directions
journal, May 2012

  • Picotti, Paola; Aebersold, Ruedi
  • Nature Methods, Vol. 9, Issue 6
  • DOI: 10.1038/nmeth.2015

Recurrent gene fusions in prostate cancer
journal, June 2008

  • Kumar-Sinha, Chandan; Tomlins, Scott A.; Chinnaiyan, Arul M.
  • Nature Reviews Cancer, Vol. 8, Issue 7
  • DOI: 10.1038/nrc2402

ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification
journal, June 2010

  • Furusato, B.; Tan, S-H; Young, D.
  • Prostate Cancer and Prostatic Diseases, Vol. 13, Issue 3
  • DOI: 10.1038/pcan.2010.23

ERG protein expression and genomic rearrangement status in primary and metastatic prostate cancer—a comparative study of two monoclonal antibodies
journal, January 2012

  • Braun, M.; Goltz, D.; Shaikhibrahim, Z.
  • Prostate Cancer and Prostatic Diseases, Vol. 15, Issue 2
  • DOI: 10.1038/pcan.2011.67

ETS2 function is required to maintain the transformed state of human prostate cancer cells
journal, December 1998

  • Sementchenko, Victor I.; Schweinfest, Clifford W.; Papas, Takis S.
  • Oncogene, Vol. 17, Issue 22
  • DOI: 10.1038/sj.onc.1202220

Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome
journal, March 2005


The erg gene: a human gene related to the ets oncogene.
journal, September 1987

  • Reddy, E. S.; Rao, V. N.; Papas, T. S.
  • Proceedings of the National Academy of Sciences, Vol. 84, Issue 17
  • DOI: 10.1073/pnas.84.17.6131

ERG Monoclonal Antibody in the Diagnosis and Biological Stratification of Prostate Cancer: Delineation of Minimal Epitope, Critical Residues for Binding, and Molecular Basis of Specificity
journal, August 2014

  • Rastogi, Anshu; Tan, Shyh-Han; Banerjee, Sreedatta
  • Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, Vol. 33, Issue 4
  • DOI: 10.1089/mab.2014.0026

Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
journal, October 2005


erg, a human ets-related gene on chromosome 21: alternative splicing, polyadenylation, and translation
journal, August 1987


Urine TMPRSS2:ERG Fusion Transcript Stratifies Prostate Cancer Risk in Men with Elevated Serum PSA
journal, August 2011


TMPRSS2-ERG-Mediated Feed-Forward Regulation of Wild-Type ERG in Human Prostate Cancers
journal, June 2011


mRNA transcript quantification in archival samples using multiplexed, color-coded probes
journal, January 2011

  • Reis, Patricia P.; Waldron, Levi; Goswami, Rashmi S.
  • BMC Biotechnology, Vol. 11, Issue 1
  • DOI: 10.1186/1472-6750-11-46

Common Gene Rearrangements in Prostate Cancer
journal, September 2011

  • Rubin, Mark A.; Maher, Christopher A.; Chinnaiyan, Arul M.
  • Journal of Clinical Oncology, Vol. 29, Issue 27
  • DOI: 10.1200/jco.2011.35.1916

5′ UTR Control of Native ERG and of Tmprss2:ERG Variants Activity in Prostate Cancer
journal, March 2013


Antibody-Based Detection of ERG Rearrangement-Positive Prostate Cancer
journal, July 2010

  • Park, Kyung; Tomlins, Scott A.; Mudaliar, Kumaran M.
  • Neoplasia, Vol. 12, Issue 7
  • DOI: 10.1593/neo.10726

The Present and Future of Prostate Cancer Urine Biomarkers
journal, June 2013

  • Rigau, Marina; Olivan, Mireia; Garcia, Marta
  • International Journal of Molecular Sciences, Vol. 14, Issue 6
  • DOI: 10.3390/ijms140612620

Predominance of ERG-negative high-grade prostate cancers in African American men
journal, August 2014

  • Farrell, James; Young, Denise; Chen, Yongmei
  • Molecular and Clinical Oncology, Vol. 2, Issue 6
  • DOI: 10.3892/mco.2014.378

Low Frequency of the ERG Oncogene Alterations in Prostate Cancer Patients from India
journal, January 2013

  • Rawal, Sudhir; Young, Denise; Williams, Molly
  • Journal of Cancer, Vol. 4, Issue 6
  • DOI: 10.7150/jca.6568

Works referencing / citing this record:

Advances in targeted proteomics and applications to biomedical research
journal, August 2016


Facile carrier-assisted targeted mass spectrometric approach for proteomic analysis of low numbers of mammalian cells
journal, August 2018

  • Shi, Tujin; Gaffrey, Matthew J.; Fillmore, Thomas L.
  • Communications Biology, Vol. 1, Issue 1
  • DOI: 10.1038/s42003-018-0107-6

Quantification of mutant SPOP proteins in prostate cancer using mass spectrometry-based targeted proteomics
journal, August 2017

  • Wang, Hui; Barbieri, Christopher E.; He, Jintang
  • Journal of Translational Medicine, Vol. 15, Issue 1
  • DOI: 10.1186/s12967-017-1276-7

A Timely Shift from Shotgun to Targeted Proteomics and How It Can Be Groundbreaking for Cancer Research
journal, February 2017

  • Faria, Sara S.; Morris, Carlos F. M.; Silva, Adriano R.
  • Frontiers in Oncology, Vol. 7
  • DOI: 10.3389/fonc.2017.00013

Quantification of mutant SPOP proteins in prostate cancer using mass spectrometry-based targeted proteomics.
text, January 2017


Quantification of mutant SPOP proteins in prostate cancer using mass spectrometry-based targeted proteomics
journal, August 2017

  • Wang, Hui; Barbieri, Christopher E.; He, Jintang
  • Journal of Translational Medicine, Vol. 15, Issue 1
  • DOI: 10.1186/s12967-017-1276-7

Noninvasive Prenatal Diagnosis Significance of ERG Methylation as a Biomarker in Down’s Syndrome
journal, January 2017


A Timely Shift from Shotgun to Targeted Proteomics and How It Can Be Groundbreaking for Cancer Research
journal, February 2017

  • Faria, Sara S.; Morris, Carlos F. M.; Silva, Adriano R.
  • Frontiers in Oncology, Vol. 7
  • DOI: 10.3389/fonc.2017.00013